Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenues:
Total revenues	$ 147,465	$ 142,273
Operating expenses:
Cost of revenues (exclusive of depreciation and amortization presented separately below)	32,684	31,188
Sales and marketing	33,087	28,783
Product development	21,199	19,963
General and administrative	32,672	31,281
Depreciation and amortization	15,115	16,768
Loss on sale and impairments	131	85
Total operating expenses	134,888	128,068
Operating income	12,577	14,205
Interest and other expense, net	(4,774)	(12,759)
Net income from continuing operations before income tax expense	7,803	1,446
Income tax expense	(632)	(512)
Net income from continuing operations	7,171	934
Loss from discontinued operations, net of income tax	0	(8,647)
Net income (loss)	7,171	(7,713)
Other comprehensive income (loss):
Foreign currency translation (loss) gain, net	(861)	477
Comprehensive income (loss)	$ 6,310	$ (7,236)
Basic net income (loss) per share attributable to common stockholders:
Continuing operations (in dollars per share)	$ 0.04	$ 0.01
Discontinued operations (in dollars per share)	0	(0.05)
Basic net income (loss) per share attributable to common stockholders (in dollars per share)	0.04	(0.04)
Diluted net income (loss) per share attributable to common stockholders:
Continuing operations (in dollars per share)	0.04	0.01
Discontinued operations (in dollars per share)	0	(0.05)
Diluted net income (loss) per share attributable to common stockholders (in dollars per share)	$ 0.04	$ (0.04)
Weighted-average shares of common stock outstanding used in computing net income (loss) per share:
Basic (in shares)	177,679,140	183,467,698
Diluted (in shares)	180,415,914	185,222,240
Subscription and transaction fees
Revenues:
Total revenues	$ 142,099	$ 137,779
Other
Revenues:
Total revenues	$ 5,366	$ 4,494